Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 2 of 2 items.
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
… Bamlanivimab - Potential Risk of Treatment Failure Due to … Key messages A potential risk of treatment failure of bamlanivimab against certain severe acute respiratory … variants was identified through global surveillance. Bamlanivimab is expected to retain neutralizing activity …
AlertHealth professional risk communication | 2021-04-28
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… Authorization of Bamlanivimab with English-only Labels for Use in Relation to … room (ER) physicians. Key messages On November 20, 2020, bamlanivimab was authorized for use in accordance with the … and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of adults and …
AlertHealth professional risk communication | 2020-12-18